Dietary supplements maker Omega Protein Corp's shareholders elected two nominees of activist investor Wynnefield Capital to the company's board, ending a months-long proxy battle.
Wynnefield and its affiliates, which together own 7.9 percent stake in Omega, have been asking the company to explore strategic alternatives, including selling itself or its assets.
This month, shareholder advisory service Institutional Shareholder Services recommended that Omega's shareholders vote for the New York-based hedge fund's nominees, Michael Christodolou and David Clarke.
